DE69231701T2 - Säure-Sphingomyelinase-Gen und Diagnose der Niemann-Pick Krankheit - Google Patents
Säure-Sphingomyelinase-Gen und Diagnose der Niemann-Pick KrankheitInfo
- Publication number
- DE69231701T2 DE69231701T2 DE69231701T DE69231701T DE69231701T2 DE 69231701 T2 DE69231701 T2 DE 69231701T2 DE 69231701 T DE69231701 T DE 69231701T DE 69231701 T DE69231701 T DE 69231701T DE 69231701 T2 DE69231701 T2 DE 69231701T2
- Authority
- DE
- Germany
- Prior art keywords
- niemann
- diagnosis
- pick disease
- acid sphingomyelinase
- sphingomyelinase gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
- A01K67/027—New breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0278—Humanized animals, e.g. knockin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/15—Humanized animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0306—Animal model for genetic diseases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/695,472 US5773278A (en) | 1991-05-03 | 1991-05-03 | Acid sphingomyelinase gene |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69231701D1 DE69231701D1 (de) | 2001-04-05 |
DE69231701T2 true DE69231701T2 (de) | 2001-09-20 |
Family
ID=24793124
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69231701T Expired - Lifetime DE69231701T2 (de) | 1991-05-03 | 1992-04-30 | Säure-Sphingomyelinase-Gen und Diagnose der Niemann-Pick Krankheit |
Country Status (4)
Country | Link |
---|---|
US (4) | US5773278A (de) |
EP (1) | EP0520843B1 (de) |
DE (1) | DE69231701T2 (de) |
IL (1) | IL101727A (de) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8349319B2 (en) | 2009-08-28 | 2013-01-08 | Mount Sinai School Of Medicine | Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5773278A (en) * | 1991-05-03 | 1998-06-30 | Mount Sinai Medical Center | Acid sphingomyelinase gene |
AU4586096A (en) * | 1995-03-10 | 1996-09-19 | Becton Dickinson & Company | Sample processing method for whole blood |
DE69625678T3 (de) † | 1995-12-18 | 2006-11-09 | The University Of Utah Research Foundation, Salt Lake City | Chromosom 13 verbundene Brustkrebsempfindlichkeitsgen BRCA2 |
US6274309B1 (en) * | 1996-07-26 | 2001-08-14 | Richard Kolesnick | Method for the modulation of acid-sphingomyelinase-related apoptosis |
US5919687A (en) * | 1996-12-24 | 1999-07-06 | John Hopkins University | Recombinant N-SMases and nucleic acids encoding same |
US6426198B1 (en) | 1997-07-03 | 2002-07-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Genes for Niemann-Pick type C disease |
US20040146879A1 (en) * | 1998-08-31 | 2004-07-29 | Bayer Healthcare Llc | Novel human genes and gene expression products |
US6262334B1 (en) * | 1998-08-31 | 2001-07-17 | Bayer Corporation | Human genes and expression products: II |
US7258973B2 (en) | 1998-08-31 | 2007-08-21 | Mayo Foundation For Medical Education & Research | Method for detecting a differentially expressed sequence |
US6642038B1 (en) * | 1999-09-14 | 2003-11-04 | Genzyme Glycobiology Research Institute, Inc. | GlcNAc phosphotransferase of the lysosomal targeting pathway |
US6770468B1 (en) | 1999-09-14 | 2004-08-03 | Genzyme Glycobiology Research Institute, Inc. | Phosphodiester-α-GlcNAcase of the lysosomal targeting pathway |
US7850984B2 (en) | 2000-02-15 | 2010-12-14 | The General Hospital Corporation | Protection of the female reproductive system from natural and artificial insults |
AU2001237050A1 (en) * | 2000-02-17 | 2001-08-27 | Genzyme Corporation | Genetic modification of the lung as a portal for gene delivery |
GB0005326D0 (en) * | 2000-03-06 | 2000-04-26 | Deutsches Krebsforsch | Enzymes and uses relating thereto |
US20030124652A1 (en) * | 2001-12-21 | 2003-07-03 | Novazyme Pharmaceuticals, Inc. | Methods of producing high mannose glycoproteins in complex carbohydrate deficient cells |
US6800472B2 (en) * | 2001-12-21 | 2004-10-05 | Genzyme Glycobiology Research Institute, Inc. | Expression of lysosomal hydrolase in cells expressing pro-N-acetylglucosamine-1-phosphodiester α-N-acetyl glucosimanidase |
US6905856B2 (en) | 2001-12-21 | 2005-06-14 | Genzyme Glycobiology Research Institute, Inc. | Soluble GlcNAc phosphotransferase |
HUE026861T2 (en) | 2003-05-01 | 2016-07-28 | Genzyme Corp | Gene Therapy For Neurometabolic Disorder |
WO2005016250A2 (en) * | 2003-08-08 | 2005-02-24 | Genzyme Corporation | Cell therapy for neurometabolic disorders |
BRPI0416434A (pt) * | 2003-11-25 | 2007-02-21 | Sinai School Medicine | métodos para aumentar a atividade de uma proteìna de ácido esfingomielinase (asm), para estender a meia-vida e prolongar a atividade de uma proteìna asm purificada, para aumentar a produção de uma proteìna asm recombinante através de uma célula hospedeira, e usos de uma composição de asm tipo alelo-selvagem, purificada e um composto análogo de ceramida ou esfingomielina, e de um composto análogo de ceramida ou de esfingomielina |
US8889127B2 (en) | 2004-07-01 | 2014-11-18 | Icahn School Of Medicine At Mount Sinai | Targeted protein replacement for the treatment of lysosomal storage disorders |
US20100028305A1 (en) * | 2005-01-04 | 2010-02-04 | Nobuko Uchida | Methods for the treatment of lysosomal storage disorders |
PT1879623E (pt) | 2005-05-02 | 2012-12-20 | Genzyme Corp | Terapia génica para distúrbios da medula espinal |
CN107007842A (zh) | 2005-05-02 | 2017-08-04 | 建新公司 | 神经代谢疾病的基因治疗 |
JP5706602B2 (ja) | 2006-02-08 | 2015-04-22 | ジェンザイム・コーポレーション | ニーマンピック病a型に対する遺伝子治療 |
GB0606190D0 (en) | 2006-03-28 | 2006-05-10 | Isis Innovation | Construct |
US8961962B2 (en) * | 2007-01-05 | 2015-02-24 | Mount Sinai School Of Medicine | Acid ceramidase and mammalian cell survival |
SI2158322T1 (sl) | 2007-06-06 | 2017-10-30 | Genzyme Corporation | Genska terapija za bolezni lizosomskega shranjevanja |
WO2009016652A1 (en) * | 2007-07-31 | 2009-02-05 | Bigtec Private Limited | A buffer system and a method for direct pcr amplification |
US8679478B2 (en) | 2010-10-04 | 2014-03-25 | Duke University | Methods of lysosomal storage disease therapy |
DK2753346T3 (da) | 2011-09-07 | 2020-05-25 | Sinai School Medicine | Ceramidase og celledifferentiering |
ES2897825T3 (es) | 2012-06-01 | 2022-03-02 | Icahn School Med Mount Sinai | Niveles de ceramida en el tratamiento y prevención de infecciones |
EP3659619A1 (de) | 2013-03-14 | 2020-06-03 | Icahn School of Medicine at Mount Sinai | Therapeutische säure-ceramidase-zusammensetzungen und verfahren zur herstellung und verwendung davon |
NZ754328A (en) | 2013-06-07 | 2021-12-24 | Genzyme Corp | Marker for acid sphingomyelinase disorders and uses thereof |
US20180104289A1 (en) | 2015-04-08 | 2018-04-19 | The United States Of America, As Represented By The Secretary, Department Of Health And Human | Viral gene therapy as treatment for cholesterol storage disease or disorder |
US10940125B2 (en) | 2015-09-18 | 2021-03-09 | Duke University | Methods and compositions for the treatment of steatosis-associated disorders |
CA3068010A1 (en) | 2017-06-20 | 2018-12-27 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Codon-optimized human npc1 genes for the treatment of niemann-pick type c1 deficiency and related conditions |
BR112020003541A2 (pt) | 2017-08-24 | 2020-09-01 | Sanofi | tratamento de condições ósseas anormais em pacientes com deficiência de esfingomielinase ácida |
UY38238A (es) | 2018-05-25 | 2019-12-31 | Genzyme Corp | Composiciones farmacéuticas para el tratamiento de la deficiencia de esfingomielinasa ácida |
CA3157700A1 (en) | 2019-10-17 | 2021-04-22 | Stridebio, Inc. | Adeno-associated viral vectors for treatment of niemann-pick disease type c |
WO2023178325A1 (en) | 2022-03-18 | 2023-09-21 | Genzyme Corporation | Pharmaceutical recombinant human acid sphingomyelinase compositions and methods |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4215051A (en) | 1979-08-29 | 1980-07-29 | Standard Oil Company (Indiana) | Formation, purification and recovery of phthalic anhydride |
IL74761A0 (en) * | 1984-04-13 | 1985-06-30 | Hughes Howard Med Inst | Human phenylalanine hydroxylase cdna clones,their production and their use in diagnosing classical phenylketonuria |
US4683195A (en) * | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US5240846A (en) * | 1989-08-22 | 1993-08-31 | The Regents Of The University Of Michigan | Gene therapy vector for cystic fibrosis |
US5773278A (en) * | 1991-05-03 | 1998-06-30 | Mount Sinai Medical Center | Acid sphingomyelinase gene |
-
1991
- 1991-05-03 US US07/695,472 patent/US5773278A/en not_active Expired - Lifetime
-
1992
- 1992-04-29 IL IL10172792A patent/IL101727A/xx not_active IP Right Cessation
- 1992-04-30 DE DE69231701T patent/DE69231701T2/de not_active Expired - Lifetime
- 1992-04-30 EP EP92401241A patent/EP0520843B1/de not_active Expired - Lifetime
-
1994
- 1994-05-27 US US08/250,740 patent/US5686240A/en not_active Expired - Lifetime
-
1998
- 1998-06-29 US US09/106,375 patent/US6541218B1/en not_active Expired - Fee Related
-
2003
- 2003-01-28 US US10/352,762 patent/US20030153739A1/en not_active Abandoned
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8349319B2 (en) | 2009-08-28 | 2013-01-08 | Mount Sinai School Of Medicine | Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency |
US8658162B2 (en) | 2009-08-28 | 2014-02-25 | Icahn School Of Medicine At Mount Sinai | Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency |
US8709408B2 (en) | 2009-08-28 | 2014-04-29 | Icahn School Of Medicine At Mount Sinai | Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency |
US9114139B2 (en) | 2009-08-28 | 2015-08-25 | Icahn School Of Medicine At Mount Sinai | Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency |
US9655954B2 (en) | 2009-08-28 | 2017-05-23 | Icahn School Of Medicine At Mount Sinai | Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency |
US10188705B2 (en) | 2009-08-28 | 2019-01-29 | Icahn School Of Medicine At Mount Sinai | Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency |
Also Published As
Publication number | Publication date |
---|---|
US20030153739A1 (en) | 2003-08-14 |
US5773278A (en) | 1998-06-30 |
IL101727A (en) | 2005-12-18 |
EP0520843A3 (en) | 1993-03-31 |
US6541218B1 (en) | 2003-04-01 |
EP0520843B1 (de) | 2001-02-28 |
US5686240A (en) | 1997-11-11 |
DE69231701D1 (de) | 2001-04-05 |
IL101727A0 (en) | 1992-12-30 |
EP0520843A2 (de) | 1992-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69231701D1 (de) | Säure-Sphingomyelinase-Gen und Diagnose der Niemann-Pick Krankheit | |
ITMI912687A0 (it) | Insieme di elementi diagnostici per diagnosticare e distinguere il dolore toracico al primo insorgere | |
DE69535509D1 (de) | Medizinische diagnostische Bilddarstellungssystem und Verfahren | |
DK186288D0 (da) | Diagnostisk saet | |
DK412189A (da) | Sonde og fremgangsmaade til diagnose for muskeldystrofi | |
DE69429202D1 (de) | Therapeutischer Wirkstoff für Erkrankungen des Verdauungstraktes | |
ATE337335T1 (de) | Oberflächenantigene und proteine für zusammensetzungen zu diagnose und vorbeugung der lyme-kkrankheit | |
DE820303T1 (de) | p277 PEPTIDANALOGE, PHARMAZEUTISCHE ZUSAMMENSTELLUNG DAVON ZUR BEHANDLUNG UND DIAGNOSE VON DIABETES | |
DE69604228T2 (de) | Pupillen Messanordnung und Alzheimer Krankheits Diagnosesystem | |
DE69509532D1 (de) | Untersuchungsgerät für eine person besonders von vestibularen evozierten potentialen | |
DK28188D0 (da) | Medicinsk diagnoseapparat | |
NO20015653D0 (no) | Diagnose og behandling av aterosklerose og koronar hjertelidelse | |
DE68918233D1 (de) | Katheter für diagnose und therapie. | |
NO883626L (no) | Fremgangsmaate for diagnose av kikhoste og testsett for utfoerelse av fremgangsmaaten. | |
FI821775A0 (fi) | Foerfarande foer framstaellning av farmakologiskt aktiva n-(aryloxialkyl)-n'-(aminoalkyl)-urea | |
DE69432561D1 (de) | Diagnose mentaler störungen | |
DE69128642D1 (de) | Immunadsorbens zur diagnose von epilepsie und der risikogruppe | |
FI821776A0 (fi) | Foerfarande foer framstaellning av farmakologiskt aktiva n-(aryltioalkyl)-n'-(aminoalkyl)-urea | |
BR9700817A (pt) | Diguanididas de ácido diarildicarboxílico substituídas processo para a sua preparação e seu emprego como medicamento ou diagnóstico bem como o medicamento contendo as mesmas | |
Estabrooks | Touching behaviors of intensive care nurses | |
AU7752687A (en) | Diagnosis of pancreatic disease | |
KR890002215U (ko) | 전자식 추진자 질환 진찰기 | |
NO922413D0 (no) | Utstyr for bruk i diagnostisering av sykdommer | |
LV12282A (lv) | Panemiens galvas smadzenu saslimsanu diferencialajai diagnostikai | |
NO893345L (no) | Prober for og fremgangsmaater for diagnose av muskulaer dystrofi. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
R071 | Expiry of right |
Ref document number: 520843 Country of ref document: EP |